SECTOR:

Other therapeutics

FUND/VEHICLE:

NFLS Direct Investment

INVESTMENT DATE:

2018

GEOGRAPHY:

North America

STATUS CURRENT/FORMER INVESTMENT:

Existing

WEBSITE:

Stealth BioTherapeutics is developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging.